Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidural triamcinolone versus triamcinolone plus hyaluronidase or erythropoietin for lumbosacral radiculopathy
IRCT20260926071198N1Phase 3Recruiting
- Sponsor
- Baqiyatallah University of Medical Sciences
- Start
- Oct 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes, Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, double-blind trial of triamcinolone, hyaluronidase and erythropoietin in lumbosacral radiculopathy (3 arms), sponsored by Baqiyatallah University of Medical Sciences. Primary endpoints: Pain and Disability. Started Oct 2026; status: recruiting.
02
Drugs
triamcinolonehyaluronidaseerythropoietin
03
Conditions
lumbosacral radiculopathy
Beyond the preview
Go deeper on IRCT20260926071198N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260926071198N1.